Afshin Habashi

DDS | Dentist



  
  10405 Tierrasanta Blvd, San Diego
  California, 92124-2603

  858-492-9300    858-492-9332 Maps & Directions
Afshin Habashi is a San Diego, California based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 10405 Tierrasanta Blvd, San Diego. Patients can reach him at 858-492-9300.
Afshin Habashi is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Afshin Habashi speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Afshin Habashi
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:10405 Tierrasanta Blvd, San Diego,
California, 92124-2603
Phone:858-492-9300
Fax:858-492-9332
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 5890002406
Enrollment ID: I20150915001423
NPI Number: 1710908660
NPI Enumeration Date: 23 Jul, 2006
NPI Last Update On: 19 Nov, 2009

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 7956 Entrada Lazanja,
San Diego, California
Zip: 92127-3620
Phone Number: 702-338-3474
Patients can reach Afshin Habashi at 10405 Tierrasanta Blvd, San Diego, California or can call to book an appointment on 858-492-9300. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.

Comments/ Reviews: